Equities research analysts at StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in a research report issued on Thursday. The firm set a “hold” rating on the stock.
Brooklyn ImmunoTherapeutics Stock Up 1.6 %
Brooklyn ImmunoTherapeutics stock opened at $1.28 on Thursday. The firm has a 50 day moving average price of $1.71 and a 200-day moving average price of $1.96. Brooklyn ImmunoTherapeutics has a twelve month low of $0.17 and a twelve month high of $10.10. The company has a market capitalization of $75.30 million, a P/E ratio of -0.56 and a beta of 4.61.
About Brooklyn ImmunoTherapeutics
Featured Stories
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- How to Read Stock Charts for Beginners
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- Where Do I Find 52-Week Highs and Lows?
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
